Dlx-6 Activators belong to a distinctive chemical class characterized by their ability to modulate gene expression, specifically targeting the Dlx-6 gene. The Dlx-6 gene is a crucial transcription factor associated with the development and patterning of various tissues, particularly in the embryonic nervous system. Dlx-6 Activators play a pivotal role in orchestrating cellular processes by binding to specific regulatory regions of the Dlx-6 gene, thereby enhancing its transcriptional activity. This activation, in turn, triggers a cascade of downstream events that influence cellular differentiation, migration, and connectivity, particularly within the context of neural development.
The molecular structure of Dlx-6 Activators is intricately designed to facilitate their interaction with the regulatory elements of the Dlx-6 gene. Through this targeted binding, these compounds exert a fine-tuned control over the genetic machinery, contributing to the intricate choreography of cellular differentiation during embryogenesis. The specificity of Dlx-6 Activators in modulating the Dlx-6 gene sets them apart within the realm of chemical classes that regulate gene expression. Research endeavors focused on unraveling the precise mechanisms underlying the interaction between Dlx-6 Activators and the Dlx-6 gene promise to deepen our understanding of fundamental biological processes, shedding light on the intricacies of developmental biology and the molecular cues that govern tissue patterning.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a plant-derived compound known to activate adenylate cyclase, leading to an increase in cAMP levels. Dlx-6, a homeobox transcription factor, can be influenced by cAMP-dependent pathways, potentially enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC has many downstream effects that can lead to the activation of various pathways. The activation of PKC might indirectly enhance the activity of Dlx-6 by triggering pathways it is involved in. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, increasing intracellular cAMP levels. The elevated cAMP can have an impact on the functional activity of Dlx-6. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase-4, which increases levels of cAMP. Increased cAMP may enhance Dlx-6 activity. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog. By increasing cAMP levels, it can influence the functional activity of Dlx-6. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Br-cGMP is a cell-permeable cGMP analog. It can influence the functional activity of Dlx-6 through cGMP-dependent pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of phosphodiesterase-5, leading to increased cGMP levels. The elevated cGMP may enhance Dlx-6 activity. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
YC-1 inhibits phosphodiesterase and increases cGMP levels. The elevated cGMP may indirectly enhance Dlx-6 activity. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside donates nitric oxide which leads to the activation of guanylate cyclase and increased cGMP levels. This can influence the functional activity of Dlx-6. | ||||||
BAY 41-2272 | 256376-24-6 | sc-202491 sc-202491A | 5 mg 25 mg | $238.00 $728.00 | 4 | |
BAY 41-2272 activates guanylate cyclase leading to increased cGMP levels. This could potentially enhance Dlx-6 activity. | ||||||